Rhythm Pharmaceuticals Inc’s recently made public that its EVP, Head of North America Lee Jennifer Kayden unloaded Company’s shares for reported $4.43 million on Nov 11 ’24. In the deal valued at $66.33 per share,66,861 shares were sold. As a result of this transaction, Lee Jennifer Kayden now holds 972 shares worth roughly $55209.6.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Shulman Joseph sold 13,281 shares, generating $882,341 in total proceeds. Upon selling the shares at $66.44, the Chief Technical Officer now owns 0 shares.
Before that, JENNIFER KAYDEN LEE bought 66,861 shares. Rhythm Pharmaceuticals Inc shares valued at $4,501,751 were divested by the Officer at a price of $67.33 per share.
Guggenheim initiated its Rhythm Pharmaceuticals Inc [RYTM] rating to a Buy in a research note published on October 21, 2024; the price target was $70. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in mid September with a ‘”a Buy”‘ rating. JMP Securities began covering RYTM with “Mkt outperform” recommendation on September 17, 2024. BofA Securities revised its rating on May 08, 2024. It rated RYTM as “a Neutral” which previously was an “a Buy”.
Price Performance Review of RYTM
On Tuesday, Rhythm Pharmaceuticals Inc [NASDAQ:RYTM] saw its stock jump 2.81% to $56.80. Over the last five days, the stock has lost -1.63%. Rhythm Pharmaceuticals Inc shares have risen nearly 23.56% since the year began. Nevertheless, the stocks have risen 20.34% over the past one year. While a 52-week high of $68.58 was reached on 11/11/24, a 52-week low of $35.17 was recorded on 05/29/24. SMA at 50 days reached $55.71, while 200 days put it at $46.74.
Levels Of Support And Resistance For RYTM Stock
The 24-hour chart illustrates a support level at 55.26, which if violated will result in even more drops to 53.71. On the upside, there is a resistance level at 57.61. A further resistance level may holdings at 58.41. The Relative Strength Index (RSI) on the 14-day chart is 47.25, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.63, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 74.44%. Stochastics %K at 12.01% indicates the stock is a buying.
How much short interest is there in Rhythm Pharmaceuticals Inc?
A steep rise in short interest was recorded in Rhythm Pharmaceuticals Inc stocks on 2024-11-29, dropping by -1.99 million shares to a total of 6.37 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 8.36 million shares. There was a decline of -31.3%, which implies that there is a negative sentiment for the stock.
